These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 37150879)
1. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies. Young AL; Vogel JW; Robinson JL; McMillan CT; Ossenkoppele R; Wolk DA; Irwin DJ; Elman L; Grossman M; Lee VMY; Lee EB; Hansson O Brain; 2023 Jul; 146(7):2975-2988. PubMed ID: 37150879 [TBL] [Abstract][Full Text] [Related]
2. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies. Young AL; Vogel JW; Robinson JL; McMillan CT; Ossenkoppele R; Wolk DA; Irwin DJ; Elman L; Grossman M; Lee VM; Lee EB; Hansson O medRxiv; 2023 Feb; ():. PubMed ID: 36778217 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer's Coordinating Center database. Woodworth DC; Nguyen KM; Sordo L; Scambray KA; Head E; Kawas CH; Corrada MM; Nelson PT; Sajjadi SA Acta Neuropathol; 2024 Jun; 147(1):103. PubMed ID: 38896163 [TBL] [Abstract][Full Text] [Related]
4. Annexin A11 aggregation in FTLD-TDP type C and related neurodegenerative disease proteinopathies. Robinson JL; Suh E; Xu Y; Hurtig HI; Elman L; McMillan CT; Irwin DJ; Porta S; Van Deerlin VM; Lee EB Acta Neuropathol; 2024 Jun; 147(1):104. PubMed ID: 38896345 [TBL] [Abstract][Full Text] [Related]
5. Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration. Robinson JL; Porta S; Garrett FG; Zhang P; Xie SX; Suh E; Van Deerlin VM; Abner EL; Jicha GA; Barber JM; Lee VM; Lee EB; Trojanowski JQ; Nelson PT Brain; 2020 Sep; 143(9):2844-2857. PubMed ID: 32830216 [TBL] [Abstract][Full Text] [Related]
7. [FTLD/ALS as TDP-43 proteinopathies]. Ishihara T; Ariizumi Y; Shiga A; Yokoseki A; Sato T; Toyoshima Y; Kakita A; Takahashi H; Nishizawa M; Onodera O Rinsho Shinkeigaku; 2010 Nov; 50(11):1022-4. PubMed ID: 21921552 [TBL] [Abstract][Full Text] [Related]
8. Glial TDP-43 and TDP-43 induced glial pathology, focus on neurodegenerative proteinopathy syndromes. Prater KE; Latimer CS; Jayadev S Glia; 2022 Feb; 70(2):239-255. PubMed ID: 34558120 [TBL] [Abstract][Full Text] [Related]
9. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological correlations in behavioural variant frontotemporal dementia. Perry DC; Brown JA; Possin KL; Datta S; Trujillo A; Radke A; Karydas A; Kornak J; Sias AC; Rabinovici GD; Gorno-Tempini ML; Boxer AL; De May M; Rankin KP; Sturm VE; Lee SE; Matthews BR; Kao AW; Vossel KA; Tartaglia MC; Miller ZA; Seo SW; Sidhu M; Gaus SE; Nana AL; Vargas JNS; Hwang JL; Ossenkoppele R; Brown AB; Huang EJ; Coppola G; Rosen HJ; Geschwind D; Trojanowski JQ; Grinberg LT; Kramer JH; Miller BL; Seeley WW Brain; 2017 Dec; 140(12):3329-3345. PubMed ID: 29053860 [TBL] [Abstract][Full Text] [Related]
11. Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years. Carlos AF; Josephs KA J Neurol; 2022 Aug; 269(8):4030-4054. PubMed ID: 35320398 [TBL] [Abstract][Full Text] [Related]
12. Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum. Shen T; Vogel JW; Duda J; Phillips JS; Cook PA; Gee J; Elman L; Quinn C; Amado DA; Baer M; Massimo L; Grossman M; Irwin DJ; McMillan CT Transl Neurodegener; 2023 Dec; 12(1):57. PubMed ID: 38062485 [TBL] [Abstract][Full Text] [Related]
13. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: From pathomechanisms to therapeutic strategies. Ho PC; Hsieh TC; Tsai KJ Ageing Res Rev; 2024 Sep; 100():102441. PubMed ID: 39069095 [TBL] [Abstract][Full Text] [Related]